Catheter-Related Bladder Discomfort: How Can We Manage It?

키워드

참고문헌 (61)

1. Platt R, "Mortality associated with nosocomial urinary-tract infection", N Engl J Med, 307, pp.637~642 (1982)
2. Lo E, "Strategies to prevent catheter-associated urinary tract infections in acute care hospitals", Infect Control Hosp Epidemiol, 29(Suppl 1), pp.S41~S50 (2008)
3. Smith PW, "SHEA", APIC guideline: infection prevention and control in the long-term care facility, July 2008, 2008, pp.29, 785~814
4. Garcia MM, "Traditional Foley drainage systems--do they drain the bladder?", J Urol, 177, pp.203~207 (2007)
5. Stickler DJ, "The encrustation and blockage of longterm indwelling bladder catheters : a way forward in prevention and control", Spinal Cord, 48, pp.784~790 (2010)
6. Samson G, "Neurogenic bladder in spinal cord injury", Phys Med Rehabil Clin N Am, 18, pp.255~274 (2007)
7. Kashefi C, "Incidence and prevention of iatrogenic urethral injuries", J Urol, 179, pp.2254~2257 (2008)
8. Kohler-Ockmore J, "Long-term catheterization of the bladder : prevalence and morbidity", Br J Urol, 77, pp.347~351 (1996)
9. Wilson M, "Causes and management of indwelling urinary catheter-related pain", Br J Nurs, 17, pp.232~239 (2008)
10. Nazarko L, "Bladder pain from indwelling urinary catheterization : case study", Br J Nurs, 16, pp.511~512 (2007)
11. Lim N, "Factors predicting catheter-related bladder discomfort in surgical patients", J Perianesth Nurs, 32, pp.400~408 (2017)
12. Agarwal A, "Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study", Br J Anaesth, 96, pp.377~380 (2006)
13. Binhas M, "Predictors of catheter-related bladder discomfort in the post-anaesthesia care unit", Ann Fr Anesth Reanim, 30, pp.122~125 (2011)
14. Srivastava VK, "Evaluation of the efficacy of solifenacin and darifenacin for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study", Minerva Anestesiol, 82, pp.867~873 (2016)
15. Bala I, "Efficacy of gabapentin for prevention of postoperative catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor", Urology, 79, pp.853~857 (2012)
16. Tauzin-Fin P, "Catheter-related bladder discomfort in post-anaesthesia care unit", Ann Fr Anesth Reanim, 31, pp.605~608 (2012)
17. Agarwal A, "The efficacy of tolterodine for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study", Anesth Analg, 101, pp.1065~1067 (2005)
18. Zhang Z, "Solifenacin is able to improve the irritative symptoms after transurethral resection of bladder tumors", Urology, 84, pp.117~121 (2014)
19. Jeffery N, "Innovations in indwelling urethral catheterisation", BJU Int, 125, pp.664~668 (2020)
20. Bai Y, "Management of catheter-related bladder discomfort in patients who underwent elective surgery", J Endourol, 29, pp.640~649 (2015)
21. Ahmed S. Zugail, "Evaluation of pain and catheter-related bladder discomfort relative to balloon volumes of indwelling urinary catheters: A prospective study", Investigative and Clinical Urology, 60(1), pp.35~39 (2019), 대한비뇨의학회[DOI]
22. Yamanishi T, "Which muscarinic receptor is important in the bladder?", World J Urol, 19, pp.299~306 (2001)
23. de Groat WC, "Anatomy and physiology of the lower urinary tract", Urol Clin North Am, 20, pp.383~401 (1993)
24. Yoshimura N, "Current and future pharmacological treatment for overactive bladder", J Urol, 168, pp.1897~1913 (2002)
25. Sulzbach LM, "Patients who experience the common but uncomfortable sensation of “needing to void”", Crit Care Nurse, 22, pp.84~87 (2002)
26. Robinson J, "Fundamental principles of indwelling urinary catheter selection", Br J Community Nurs, 9, pp.281~284 (2004)
27. Andersson KE, "Pharmacology of the lower urinary tract : basis for current and future treatments of urinary incontinence", Pharmacol Rev, 56, pp.581~631 (2004)
28. Andersson KE, "Antimuscarinics for treatment of overactive bladder", Lancet Neurol, 3, pp.46~53 (2004)
29. Ikeda K, "M(3)receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland", Naunyn Schmiedebergs Arch Pharmacol, 366, pp.97~103 (2002)
30. Kobayashi S, "Comparison of in vitro selectivity profiles of solifenacin succinate(YM905)and current antimuscarinic drugs in bladder and salivary glands : a Ca2+ mobilization study in monkey cells", Life Sci, 74, pp.843~853 (2004)
31. 최훈, "Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study", International Neurourology Journal, 22(1), pp.51~57 (2018), 대한배뇨장애요실금학회
32. Sheng-Mou Hsiao, "Urodynamic and Bladder Diary Factors Predict Overactive Bladderwet in Women: A Comparison With Overactive Bladder-dry", International Neurourology Journal, 23(1), pp.69~74 (2019), 대한배뇨장애요실금학회[DOI]
33. Bum Sik Tae, "Seasonal Variation of Overactive Bladder Symptoms in Female Patients", International Neurourology Journal, 23(4), pp.334~340 (2019), 대한배뇨장애요실금학회[DOI]
34. Chung JM, "Evaluation of the efficacy of solifenacin for preventing catheter-related bladder discomfort after transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer: a prospective, randomized, multicenter study", Clin Genitourin Cancer, 15, pp.157~162 (2017)
35. Yamada S, "Basic and clinical aspects of antimuscarinic agents used to treat overactive bladder", Pharmacol Ther, 189, pp.130~148 (2018)
36. Yamada S, "In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice", Life Sci, 80, pp.127~132 (2006)
37. Kim Y, "Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways", Urology, 65, pp.238~242 (2005)
38. Jirschele K, "Oxybutynin: past, present, and future", Int Urogynecol J, 24, pp.595~604 (2013)
39. Biardeau X, "We should not use oxybutynin chloride in OAB", Neurourol Urodyn, 36, pp.822~823 (2017)
40. Tauzin-Fin P, "Sublingual oxybutynin reduces postoperative pain related to indwelling bladder catheter after radical retropubic prostatectomy", Br J Anaesth, 99, pp.572~575 (2007)
41. Guay DR, "Tolterodine, a new antimuscarinic drug for treatment of bladder overactivity", Pharmacotherapy, 19, pp.267~280 (1999)
42. Yokoyama O, "Effects of tolterodine on an overactive bladder depend on suppression of C-fiber bladder afferent activity in rats", J Urol, 174, pp.2032~2036 (2005)
43. Hur M, "Comparative effectiveness of interventions for managing postoperative catheter-related bladder discomfort : a systematic review and network meta-analysis", J Anesth, 33, pp.197~208 (2019)
44. Sasaki K, "Oral gabapentin(neurontin)treatment of refractory genitourinary tract pain", Tech Urol, 7, pp.47~49 (2001)
45. Carbone A, "Gabapentin treatment of neurogenic overactive bladder", Clin Neuropharmacol, 29, pp.206~214 (2006)
46. Kim YT, "Gabapentin for overactive bladder and nocturia after anticholinergic failure", Int Braz J Urol, 30, pp.275~278 (2004)
47. Agarwal A, "An evaluation of the efficacy of gabapentin for prevention of catheterrelated bladder discomfort: a prospective, randomized, placebocontrolled, double-blind study", Anesth Analg, 105, pp.1454~1457 (2007)
48. Maghsoudi R, "Comparing the efficacy of tolterodine and gabapentin versus placebo in catheter related bladder discomfort after percutaneous nephrolithotomy : a randomized clinical trial", J Endourol, 32, pp.168~174 (2018)
49. Marencak J, "Investigation of the clinical efficacy and safety of pregabalin alone or combined with tolterodine in female subjects with idiopathic overactive bladder", Neurourol Urodyn, 30, pp.75~82 (2011)
50. Clarke H, "The prevention of chronic postsurgical pain using gabapentin and pregabalin : a combined systematic review and meta-analysis", Anesth Analg, 115, pp.428~442 (2012)
51. Thorpe AJ, "The alpha2-delta protein : an auxiliary subunit of voltage-dependent calcium channels as a recognized drug target", Curr Opin Investig Drugs, 11, pp.761~770 (2010)
52. Kavoussi R, "Pregabalin : from molecule to medicine", Eur Neuropsychopharmacol, 16(Suppl 2), pp.S128~S133 (2006)
53. Loutochin O, "Effect of the anticonvulsant medications pregabalin and lamotrigine on urodynamic parameters in an animal model of neurogenic detrusor overactivity", Neurourol Urodyn, 31, pp.1197~1202 (2012)
54. Srivastava VK, "The efficacy of pregabalin for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled double-blind study", J Anesth, 29, pp.212~216 (2015)
55. 고광진, "A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure", International Neurourology Journal, 23(1), pp.30~39 (2019), 대한배뇨장애요실금학회[DOI]
56. M.A. Elbaset, "Assessment of Anticholinergic Use After Fading of BTX-A Effects in Refractory Idiopathic Overactive Bladder: A Prospective Blinded Randomized Trial", International Neurourology Journal, 23(3), pp.240~248 (2019), 대한배뇨장애요실금학회[DOI]
57. Kuo HC, "Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents", Urology, 63, pp.868~872 (2004)
58. Vladimír Šámal, "Intravesical Loss of OnabotulinumtoxinA During Endoscopic Intradetrusor Injection - A Multicenter Experience", International Neurourology Journal, 24(1), pp.59~65 (2020), 대한배뇨장애요실금학회[DOI]
59. Guang-Ping Li, "Efficacy and Safety of OnabotulinumtoxinA in Patients With Neurogenic Detrusor Overactivity Caused by Spinal Cord Injury: A Systematic Review and Meta-Analysis", International Neurourology Journal, 22(4), pp.275~286 (2018), 대한배뇨장애요실금학회
60. Hamilton Trinh, "Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation", International Neurourology Journal, 23(3), pp.226~233 (2019), 대한배뇨장애요실금학회[DOI]
61. Young MJ, "Another therapeutic role for intravesical botulinum toxin : patients with long-stay catheters and refractory bladder pain and catheter bypass leakage", Eur Urol Focus, 6, pp.339~343 (2020)

관련 논문AI추천